How have EXDI shares performed in 2024?

Exactus' stock was trading at $0.0650 at the beginning of 2024. Since then, EXDI stock has increased by 0.0% and is now trading at $0.0650. View the best growth stocks for 2024 here .

When did Exactus' stock split?

Exactus shares reverse split on Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Exactus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC) , VIVUS (VVUS) , Akero Therapeutics (AKRO) , CymaBay Therapeutics (CBAY) , Cumberland Pharmaceuticals (CPIX) , Entasis Therapeutics (ETTX) , Evelo Biosciences (EVLO) , Kaleido Biosciences (KLDO) .

How do I buy shares of Exactus?

Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:EXDI

Exactus (EXDI) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free EXDI Stock Alerts

$0.07

-0.01 (-10.96%)

(As of 10/27/2021)

Compare

Today's Range: $0.05
▼
$0.07
50-Day Range: $0.07
▼
$0.07
52-Week Range: $0.04
▼
$0.27

Volume: 257,300 shs
Average Volume: 83,144 shs
Market Capitalization: $38.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Exactus alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Exactus Stock (OTCMKTS:EXDI)

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

EXDI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EXDI Stock News Headlines

February 7, 2024 | news.yahoo.com

Clapham chemical attack – live: Suspect Abdul Ezedi was ‘very angry’ after sister was shot dead

June 4, 2023 | investing.com

Starbreeze AB B (STZEb)

April 16, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 30, 2021 | finanznachrichten.de

Exactus Inc.: CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in World

October 26, 2021 | finance.yahoo.com

Exactus, Inc. to Present at BIO CEO & Investor Conference

October 15, 2021 | finanznachrichten.de

Exactus Inc.: Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State University

October 14, 2021 | finance.yahoo.com

Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State University

See More Headlines

Receive EXDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & Botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:EXDI
CUSIP: N/A
CIK: 1552189
Web: www.exactusinc.com
Phone: 804-205-5036
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,460,000.00
Net Margins: N/A
Pretax Margin: -15,131.74%
Return on Equity: -3,272.69%
Return on Assets: -185.29%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.32
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $2.07 million
Price / Sales: 18.81
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.09) per share
Price / Book: -0.72

Miscellaneous

Outstanding Shares: 599,005,000
Free Float: 209,652,000
Market Cap: $38.94 million
Optionable: Not Optionable
Beta: 4.21

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Emiliano Aloi
President and Interim CEO
Kenneth E. Puzder
Chief Financial Officer and Director
Andrew Johnson
Chief Strategy Officer
Bobby Yampolsky
Interim Chairman

Key Competitors

View All Competitors

EXDI Stock Analysis - Frequently Asked Questions

How have EXDI shares performed in 2024?: Exactus' stock was trading at $0.0650 at the beginning of 2024. Since then, EXDI stock has increased by 0.0% and is now trading at $0.0650.
View the best growth stocks for 2024 here.
When did Exactus' stock split?: Exactus shares reverse split on Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.
What other stocks do shareholders of Exactus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).
How do I buy shares of Exactus?: Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EXDI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial